GSK
Price
$37.86
Change
+$0.28 (+0.75%)
Updated
Aug 8, 10:37 AM (EDT)
Capitalization
88.13B
82 days until earnings call
OGN
Price
$9.07
Change
-$0.04 (-0.44%)
Updated
Aug 8, 10:48 AM (EDT)
Capitalization
4.73B
83 days until earnings call
Interact to see
Advertisement

GSK vs OGN

Header iconGSK vs OGN Comparison
Open Charts GSK vs OGNBanner chart's image
GSK
Price$37.86
Change+$0.28 (+0.75%)
Volume$2.4K
Capitalization88.13B
Organon & Co
Price$9.07
Change-$0.04 (-0.44%)
Volume$7.22K
Capitalization4.73B
GSK vs OGN Comparison Chart in %
Loading...
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GSK vs. OGN commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a Hold and OGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (GSK: $37.58 vs. OGN: $9.11)
Brand notoriety: GSK and OGN are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GSK: 69% vs. OGN: 144%
Market capitalization -- GSK: $88.13B vs. OGN: $4.73B
GSK [@Pharmaceuticals: Major] is valued at $88.13B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • GSK’s FA Score: 2 green, 3 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, GSK is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 5 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • GSK’s TA Score: 5 bullish, 4 bearish.
  • OGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GSK is a better buy in the short-term than OGN.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а +1.16% price change this week, while OGN (@Pharmaceuticals: Major) price change was -6.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.67%. For the same industry, the average monthly price growth was +6.06%, and the average quarterly price growth was +13.68%.

Reported Earning Dates

GSK is expected to report earnings on Oct 29, 2025.

OGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GSK($88.1B) has a higher market cap than OGN($4.73B). GSK has higher P/E ratio than OGN: GSK (14.01) vs OGN (4.64). GSK YTD gains are higher at: 13.633 vs. OGN (-37.674). GSK has higher annual earnings (EBITDA): 9.08B vs. OGN (1.44B). GSK has more cash in the bank: 4.99B vs. OGN (693M). OGN has less debt than GSK: OGN (8.76B) vs GSK (18B). GSK has higher revenues than OGN: GSK (30.3B) vs OGN (6.26B).
GSKOGNGSK / OGN
Capitalization88.1B4.73B1,863%
EBITDA9.08B1.44B633%
Gain YTD13.633-37.674-36%
P/E Ratio14.014.64302%
Revenue30.3B6.26B484%
Total Cash4.99B693M720%
Total Debt18B8.76B205%
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
29
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GSKOGN
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 5 days ago
58%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 4 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
55%
Aroon
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNGEX67.680.15
+0.22%
American Funds New Economy R4
GGOTX16.26N/A
N/A
Goldman Sachs Mid Cap Growth Inv
EMRZX16.49N/A
N/A
VanEck Emerging Markets Z
SNPTX19.96N/A
N/A
DWS Equity Sector Strategy Institutional
CLXRX59.17N/A
N/A
Columbia Large Cap Index Inst2

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
+2.26%
NVS - GSK
67%
Closely correlated
+2.13%
AZN - GSK
64%
Loosely correlated
+0.12%
PFE - GSK
56%
Loosely correlated
+1.25%
SNY - GSK
53%
Loosely correlated
+2.71%
AMGN - GSK
51%
Loosely correlated
+0.01%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+4.47%
BIIB - OGN
41%
Loosely correlated
-3.87%
LLY - OGN
41%
Loosely correlated
-14.14%
GSK - OGN
38%
Loosely correlated
+2.26%
SNY - OGN
36%
Loosely correlated
+2.71%
JNJ - OGN
36%
Loosely correlated
+0.55%
More